.png "Janet Woodcock"){kind=small}
Robert Califf
Search results
Janet Woodcock. Janet Woodcock (born August 29, 1948) is an American physician serving as Principal Deputy Commissioner of Food and Drugs, having previously served as Acting Commissioner of the U.S. Food and Drug Administration (FDA). [2] She joined the FDA in 1986, and has held a number of senior leadership positions there, including terms as ...
- Roger Miller
- Robert Califf
Feb 17, 2022 · She served as the Acting Commissioner of Food and Drugs from Jan. 20, 2021 until Feb. 17, 2022. Dr. Woodcock began her FDA career in 1986 at the Center for Biologics Evaluation and Research (CBER ...
- Principal Deputy Commissioner
- Office of The Commissioner
People also ask
How old is Janet Woodcock?
When did Dr Woodcock become FDA Deputy Commissioner?
What happened to Janet Jackson?
Nov 16, 2023 · Win McNamee via Getty Images. Janet Woodcock, a top Food and Drug Administration official who had been on the short list to head the agency under President Joe Biden, will retire in early 2024 after 37 years at the regulator. Her retirement, first reported by Politico, was announced in an agency-wide message from Commissioner Robert Califf.
Jan 29, 2024 · This Wednesday will be Dr. Janet Woodcock’s last day at the US Food and Drug Administration (FDA), capping a remarkable 38-year career at the agency. She’s been called one of the most powerful and influential drug regulators worldwide. Last Thursday, Focus sat down with Woodcock in her office at FDA’s White Oak campus, where she reflected ...
Nov 30, 2023 · For almost 40 years, Janet Woodcock has provided leadership across the entire spectrum of FDA regulation. Her retirement was inevitable — there has been speculation every year for the past decade — but now it’s real. It has been officially announced that she will retire from federal service in early 2024.
Jan 20, 2021 · Janet Woodcock was named Acting Commissioner of Food and Drugs on January 20, 2021. As Acting Commissioner, Dr. Woodcock oversees the full breadth of the FDA portfolio and execution of the Federal Food, Drug, and Cosmetic Act and other applicable laws. This includes assuring the safety, effectiveness, and security of human and veterinary drugs ...
Nov 16, 2023 · U.S. Food and Drug Administration (FDA) Principal Deputy Commissioner Dr. Janet Woodcock, who led the regulator during the height of the COVID-19 pandemic as acting chief, plans to retire early ...
